Is IDEXX LABORATORIES INC /DE (IDXX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 2.0% / 30% | 0.4% / 30% | 1.4% / 30% | 0.07% / 5% | ✓ HALAL |
| DJIM | 2.0% / 33% | 0.4% / 33% | 1.4% / 33% | 0.07% / 5% | ✓ HALAL |
| MSCI | 29.1% / 33% | 5.4% / 33% | 20.7% / 33% | 0.07% / 5% | ✓ HALAL |
| S&P | 2.0% / 33% | 0.4% / 33% | 1.4% / 33% | 0.07% / 5% | ✓ HALAL |
| FTSE | 29.1% / 33% | 5.4% / 33% | 20.7% / 50% | 0.07% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 61.8% | |
| Operating Margin | 29.8% | |
| Net Margin | 24.6% | |
| Return on Equity (ROE) | 66.2% | |
| Return on Assets (ROA) | 25.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1.2B |
| Free Cash Flow | $1.0B |
| Total Debt | $976M |
| Debt-to-Equity | 60.8 |
| Current Ratio | 1.2 |
| Total Assets | $3.4B |
Price & Trading
| Last Close | $573.29 |
| 50-Day MA | $632.97 |
| 200-Day MA | $636.38 |
| Avg Volume | 501K |
| Beta | 1.7 |
|
52-Week Range
$356.14
| |
About IDEXX LABORATORIES INC /DE (IDXX)
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Purification Calculator
As a halal stock with 0.07% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is IDEXX LABORATORIES INC /DE (IDXX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), IDEXX LABORATORIES INC /DE is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is IDEXX LABORATORIES INC /DE's debt ratio?
IDEXX LABORATORIES INC /DE's debt ratio is 2.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 29.1%.
Does IDEXX LABORATORIES INC /DE require dividend purification?
Yes, IDEXX LABORATORIES INC /DE has an impermissible income ratio of 0.07%, which means 0.07% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are IDEXX LABORATORIES INC /DE's key financial metrics?
IDEXX LABORATORIES INC /DE has a market capitalization of $44.6B, trailing P/E ratio of 42.8, and revenue of $4.3B. The company maintains a gross margin of 61.8% and a net margin of 24.6%. Return on equity stands at 66.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.